Financial Times column compares AI ethics debate to early genomics

In short: A Financial Times opinion columnist says the AI field can address ethical worries by learning from how genomics did it, and by avoiding unrealistic claims.

What's going on

Ewan Birney, a genomics researcher and director at the European Bioinformatics Institute, argues that today’s AI boom looks a lot like the early 2000s rise of genomics. Genomics is the study of DNA, the instruction manual inside living things. He says both fields moved quickly, attracted big money, and sparked public concern before laws could catch up.

Birney points to real scientific progress from AI in biology, including AlphaFold, a system that predicts how proteins fold into shapes. (Proteins are tiny working parts in our cells, and their shape helps determine what they do.) He also notes that many AI methods work through heavy trial and error, more like testing many keys until one opens a lock than following a simple recipe.

At the same time, he warns that some public claims about AI, such as curing all diseases within five years, are overconfident. Birney argues that many diseases are still hard to define and even harder to prove a cure for, especially when the human brain is involved.

What to watch

Birney says genomics eventually responded to ethical concerns like genetic privacy, gene patenting, and fears of eugenics by funding ethics research, setting up review processes, and passing anti-discrimination laws. His message for AI is similar: build clear principles first, then create rules that can handle real cases as they appear. He also warns that if headlines promise too much and fall short, trust in the whole field can suffer.

Source: Financial Times